Showing results (51-60 of 499) with videos related to
Sort By:
Pageof 50
Journal of X-Ray Science and Technology|February 20, 2025
Research on meshing method for industrial CT volume data based on iterative smooth signed distance surface reconstructionShiBo Jiang, Shuo Xu, YueWen Sun, et al.Journal of Visualized Experiments : Jove|May 19, 2011
Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detectionLanying Du, Xiujuan Zhang, Jixiang Liu, et al.Reviews in Medical Virology|April 11, 2016
A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of actionJie Yang, Shuwen Liu, Lanying Du, et al.Expert Review of Vaccines|March 18, 2016
Vaccines for the prevention against the threat of MERS-CoVLanying Du, Wanbo Tai, Yusen Zhou, et al.Antimicrobial Agents and Chemotherapy|April 28, 2005
Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infectionShuwen Liu, Hong Lu, A Robert Neurath, et al.Journal of Biomolecular Screening|January 9, 2004
Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41Shuwen Liu, Louise Boyer-Chatenet, Hong Lu, et al.Biochemical and Biophysical Research Communications|September 3, 2008
Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitopeJing Li, Xi Chen, Shibo Jiang, et al.Emerging Microbes & Infections|June 4, 2015
Receptor binding and transmission studies of H5N1 influenza virus in mammalsHanjun Zhao, Jie Zhou, Shibo Jiang, et al.Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
Development of subunit vaccines against severe acute respiratory syndromeLanying Du, Yuxian He, Shibo Jiang, et al.Emerging Microbes & Infections|June 4, 2015
Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccinesShibo Jiang, Lu Lu, Qi Liu, et al.Pageof 50